Skip to main content

firsekibart

firsekibart: 1 clinical trial tracked.

firsekibart evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about firsekibart, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (1)

Efficacy and Safety of IL-1 Inhibitors in the Treatment of Mild to Moderate Systemic Lupus Erythematosus With Inadequate Response to Conventional Therapy: A Single-Centre, Single-Arm, Pilot Study

NCT07381465Registry updated 2026-07-15·Phase 4
Active, not recruiting

Primary endpoint: the percentage of patients achieving an BICLA response at the end of 12 weeks

Interventionalopen15 targetStarted 2026-06Completion 2027-121 site · ChinaChinese SLE Treatment And Research Group